NICER.
Welcome to NICER.
A collaborative multidisciplinary community.
Clinical Program
UNHIDE Program
Uncovering NICER Hematologic and Immunologic Disease Enigmas (UNHIDE) Program
The UNHIDE program was conceptualized by a multi-disciplinary group of clinicians and scientists who are invested in the diagnosis and care of patients with known or suspected genetically-driven disorders of blood and immunity. This program was created to facilitate the sharing of expertise and resources for care of these complex patients. Our goal is to help providers and families in any way we can by matching content specialists with local providers in a time sensitive manner.
About Us
North American Immuno-Hematology Clinical Education & Research Consortium
The mission of the NICER consortium is to provide a collaborative multidisciplinary environment to advance the education, clinical care, and research involving pediatric and adult patients with immuno-hematologic disorders.
Scope: The target patient population encompasses all disorders within immuno-hematology including those with complex immune cytopenias, bone marrow failure, lymphoproliferative and histiocytic disorders, immune deficiencies, autoinflammatory disorders and immune dysregulatory syndromes along with emerging phenotypes of a similar nature. Given that institutional referral patterns and expertise vary, NICER is committed to being purposefully inclusive of pediatric and adult providers from multiple disciplines including, allergy/immunology, genetics, hematology/oncology, hematopoietic stem cell transplant, rheumatology, infectious disease, gastroenterology, endocrinology, etc. to enrich the educational environment and research goals of the consortium.
Goals:
-
Establish a network of clinicians and researchers with interest and expertise, to share ideas, provide care and study patients with immuno-hematologic disorders.
-
Utilize the collective experiences and the multi-disciplinary expertise within the consortium to provide a unique learning and mentoring environment open to both members and non-members.
-
Leverage the pooled, diverse resources of the members to create a platform for clinical trials, basic science, and translational research with the development of a clinically annotated database, biorepository and network of member centers unified via a central IRB.
-
Partner with academic societies, institutes and foundations with mutual objectives, to empower the educational initiatives and accelerate research discoveries in areas related to immuno-hematology.